London’s cocoa market blighted by ‘poisoned pill’

  • 📰 FT
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 51%

Brasil Notícia Notícia

Brasil Últimas Notícias,Brasil Manchetes

Poorer quality stock in UK warehouses has led to a rare divergence in prices with the New York market

A frantic hunt by chocolate manufacturers for high-grade cocoa has left a backlog of old, poor-quality beans lying in London’s warehouses, leading to a rare divergence in prices between the UK and the US. Last month cocoa futures traded in New York rose strongly, peaking above $10,000 last week, while London prices fell, dipping below $6,400 earlier this month.

These new rules oblige traders and chocolate companies to prove that the cocoa they import into the EU was not grown on deforested land. Some industry traders and executives had hoped the incoming rules would allow the lower-grade material to be written off as unusable. But the EU allowed older, existing stocks to be “grandfathered” into the bloc — meaning they could still be bought and sold.

 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 113. in BR

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Pharma companies' strategies for reaching poorer countries remain unclearPharmaceutical companies must prioritize efforts to reach patients in underserved parts of the world with medicines such as insulin for diabetics and, crucially, measure the effectiveness of these efforts, says Jayasree Iyer, CEO of the Access to Medicine Foundation.
Fonte: NewsMedical - 🏆 19. / 71 Consulte Mais informação »

Pharma companies' strategies for reaching poorer countries remain unclearPharmaceutical companies must prioritize efforts to reach patients in underserved parts of the world with medicines such as insulin for diabetics and, crucially, measure the effectiveness of these efforts, says Jayasree Iyer, CEO of the Access to Medicine Foundation.
Fonte: NewsMedical - 🏆 19. / 71 Consulte Mais informação »